Financing momentum Recent $10M financing rounds from iGan Partners and fintech/industry-backed investors create runway for expanded sales efforts, new market outreach, and scaling manufacturing and service capabilities.

Regulatory credibility CE Mark, FDA 510(k) and Health Canada approvals for ExactVu and FusionVu strengthen buyer confidence across regions, enabling faster procurement decisions in hospitals and clinics.

Horizon expansion Global adoption in urology with high-resolution micro-ultrasound presents opportunities to upsell to existing customers with FusionVu integration and potential extensions into abdominal imaging accessories.

Workflow alignment System is designed as an extension of current urological workflow, offering ease of adoption for clinics; target institutions should be prioritized where biopsy targeting and MRI fusion needs are growing.

Strategic partnerships Past collaborations with Cambridge Consultants and strategic funding partners indicate openness to ecosystem alliances; pursue co-marketing, distribution, and integrator partnerships to widen market reach and accelerate adoption.